Outcomes | Experimental group (n=60) | Control group (n=60) | Effect estimated (95% CI) | p-value |
---|---|---|---|---|
Primary outcomes | ||||
Cases of rNMB after extubation (TOF ratio <0.9), n (%) | 45 (75.0) | 44 (73.3) | 1.02 (0.83 to 1.26)a | 0.84 |
Cases of patients with TOF ratio < 0.3, n (%) | 12 (20) | 0 (0) | 31.12 (1.89 to 512.61)a | 0.00 |
Secondary outcomes | ||||
Cases of neostigmine-induced muscle paralysis, n (%) | 0 (0) | 0 (0) | - | - |
End of surgery – extubation interval (min), mean±SD | 8.9 ± 5.1 | 9.6 ± 4.5 | −0.70 (−2.42 to 1.02)b | 0.40 |
End of surgery – exit OR interval (min), mean±SD | 13.6 ± 5.2 | 15.7 ± 5.6 | −2.10 (−3.70 to −0.50)b | 0.04 |
The length of stay in the PACU (min), mean±SD | 45.1 ± 15.6 | 46.0 ± 13.5 | −0.90 (−6.12 to 4.32)b | 0.73 |
Cases of hypoxia, n (%) | ||||
In OR | 2 (3.3) | 1(1.7) | 2.00 (0.19 to 21.47)a | 0.56 |
In PACU | 0 (0) | 0 (0) | - | - |
Cases of children who required assisted ventilation, n (%) | ||||
In OR | 2 (3.3) | 1 (1.7) | 2.00 (0.19 to 21.47)a | 0.56 |
In PACU | 0 (0) | 0 (0) | - | - |
Cases of bradycardia, n (%) | ||||
In OR | 0 (0) | 0 (0) | - | - |
In PACU | 0 (0) | 0 (0) | - | - |
Cases of nausea and vomiting, n (%) | ||||
In PACU | 0 (0) | 0 (0) | - | - |
On the first postoperative day | 1 (1.7) | 0 (0) | 3.00 (0.12 to 72.20)a | 0.32 |